Stem cells and tissue engineering: an alternative treatment for craniofacial congenital malformations and articular degenerative diseases

Cristina Velasquillo , Antonio Madrazo-Ibarra , Claudia Gutiérrez- Gómez , Marcia Rosario Pérez-Dosal , Yaaziel Melgarejo-Ramírez , Clemente Ibarra

Plastic and Aesthetic Research ›› 2020, Vol. 7 ›› Issue (1) : 31

PDF
Plastic and Aesthetic Research ›› 2020, Vol. 7 ›› Issue (1) :31 DOI: 10.20517/2347-9264.2020.30
Review
Review
Stem cells and tissue engineering: an alternative treatment for craniofacial congenital malformations and articular degenerative diseases
Author information +
History +
PDF

Abstract

The life quality of patients with craniofacial malformations is severely affected by the physical disabilities caused by the malformation itself, but also by being subjected to bullying, which leads to a series of relevant psychological and societal effects that have an economic impact on the health sector. Orofacial clefts, notably cleft lip (CL), cleft palate, and microtia, are the most common craniofacial birth defects in humans and represent a substantial burden, both personal and societal. On the other hand, osteoarthritis is a widespread degenerative disease that is becoming more common due to the extension of the human lifespan and to an increase in injuries in young people as a result of their lifestyle. Advances in tissue engineering as a part of regenerative medicine offer new hope to patients that can benefit from new tissue engineering therapies based on the supportive action of tailored 3D biomaterials and the synergic action of stem cells that can be driven to the process of bone and cartilage regeneration. This review provides an update on recent considerations for stem cells and studies on the use of advanced biomaterials and cell therapies for the regeneration of craniofacial congenital malformations and articular degenerative diseases.

Keywords

Mesenchymal stromal cells / microtia / cartilage / cleft lip / cleft palate

Cite this article

Download citation ▾
Cristina Velasquillo, Antonio Madrazo-Ibarra, Claudia Gutiérrez- Gómez, Marcia Rosario Pérez-Dosal, Yaaziel Melgarejo-Ramírez, Clemente Ibarra. Stem cells and tissue engineering: an alternative treatment for craniofacial congenital malformations and articular degenerative diseases. Plastic and Aesthetic Research, 2020, 7(1): 31 DOI:10.20517/2347-9264.2020.30

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

NCI Dictionary of Cancer Terms [Internet]. National Cancer Institute. 2011. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms [Last accessed on 12 Jun 2020]

[2]

Dominici M,Mueller I,Marini F.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement..Cytotherapy2006;8:315-7

[3]

Blau HM.Stem cells in the treatment of disease..N Engl J Med2019;380:1748-60

[4]

Glenn JD.Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy..World J Stem Cells2014;6:526 PMCID:PMC4178253

[5]

Maumus M,Noël D.Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes..Biochimie2013;95:2229-34

[6]

Niu CC,Yuan LJ,Pan TL.Identification of mesenchymal stem cells and osteogenic factors in bone marrow aspirate and peripheral blood for spinal fusion by flow cytometry and proteomic analysis..J Orthop Surg2014;9:32 PMCID:PMC4037761

[7]

Samsonraj RM,Sathiyanathan P,Rötzschke O.Establishing criteria for human mesenchymal stem cell potency: establishing criteria for hMSC potency..Stem Cells2015;33:1878-91 PMCID:PMC5363381

[8]

Ben Nasr M,Avruch J,Kefaloyianni E.Co-transplantation of autologous MSC delays islet allograft rejection and generates a local immunoprivileged site..Acta Diabetol2015;52:917-27 PMCID:PMC4968999

[9]

Ferreira ML,Alvarez Silva LH,Conilho Macedo Müller LC.Heterologous mesenchymal stem cells successfully treat femoral pseudarthrosis in rats..J Transl Med2012;10:51 PMCID:PMC3334676

[10]

Rodriguez RL,Bunnell BA,March KL.Arguments for a different regulatory categorization and framework for stromal vascular fraction..Stem Cells Dev2020;29:257-62

[11]

Chu DT,Tien NLB,Minh LB.Adipose tissue stem cells for therapy: an update on the progress of isolation, culture, storage, and clinical application..J Clin Med2019;8:917 PMCID:PMC6678927

[12]

Lander EB.Autologous stromal vascular fraction: a new era of personal cell therapy..Stem Cells Res Dev Ther2018;4:1-6

[13]

Osteoarthritis Research Society International (OARSI) [Internet]. Available from: https://www.oarsi.org/ [Last accessed on 12 Jun 2020]

[14]

GBD Compare | IHME Viz Hub [Internet]. Available from: http://vizhub.healthdata.org/gbd-compare [Last accessed on 12 Jun 2020]

[15]

Woolf AD.Burden of major musculoskeletal conditions..Bull World Health Organ2003;81:646-56 PMCID:PMC2572542

[16]

Hunter DJ.Osteoarthritis..Lancet2019;393:1745-59

[17]

Martel-Pelletier J,Cicuttini FM,Cooper C.Osteoarthritis..Nat Rev Dis Primer2016;2:16072

[18]

McAlindon TE,Sullivan MC,Berenbaum F.OARSI guidelines for the non-surgical management of knee osteoarthritis..Osteoarthritis Cartilage2014;22:363-88

[19]

Villalobos Córdoba FE,Almazan A,Pérez Jiménez FJ.Articular cartilage injuries in 1,309 knee arthroscopies, a public health problem in a developing country?.Osteoarthritis Cartilage2007;15:B102

[20]

Brittberg M,Nilsson A,Isaksson O.Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation..N Engl J Med1994;331:889-95

[21]

Everhart JS,Abouljoud MM,Flanigan DC.Cost-efficacy of knee cartilage defect treatments in the United States..Am J Sports Med2019;363546519834557:

[22]

Orth P,Madry H.Microfracture for cartilage repair in the knee: a systematic review of the contemporary literature..Knee Surg Sports Traumatol Arthrosc2020;28:670-706

[23]

Thorlund JB,Roos EM.Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms..BMJ2015;350:h2747 PMCID:PMC4469973

[24]

Lohmander LS,Dreher D,Kruger DS.Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial: sprifermin effects in knee osteoarthritis..Arthritis Rheumatol2014;66:1820-31

[25]

Zhang W,Dass CR.Current research on pharmacologic and regenerative therapies for osteoarthritis..Bone Res2016;4:15040 PMCID:PMC4772471

[26]

Poulet B.New developments in osteoarthritis and cartilage biology..Curr Opin Pharmacol2016;28:8-13

[27]

Wang AT,Jia HH,Yu H.Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: a concise review..World J Stem Cells2019;11:222-35 PMCID:PMC6503460

[28]

Ibarra C,Villalobos E,Lombardero G.Follow-up of a new arthroscopic technique for implantation of matrix-encapsulated autologous chondrocytes in the knee..Arthrosc J Arthrosc Relat Surg2014;30:715-23

[29]

Villalobos E,Martínez V,Velasquillo C.Arthroscopic matrix-encapsulated autologous chondrocyte implantation: a pilot multicenter investigation in Latin America..Cartilage2020;11:

[30]

Brittberg M,Ilgenfritz J.Matrix-applied characterized autologous cultured chondrocytes versus microfracture: five-year follow-up of a prospective randomized trial..Am J Sports Med2018;46:1343-51

[31]

Schuette HB,McCarty EC.Matrix-assisted autologous chondrocyte transplantation in the knee: a systematic review of mid- to long-term clinical outcomes..Orthop J Sports Med2017;5:232596711770925 PMCID:PMC5464387

[32]

MACI (Autologous Cultured Chondrocytes on a Porcine Collagen Membrane). Available from: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/maci-autologous-cultured-chondrocytes-porcine-collagen-membrane [Last accessed on 12 Jun 2020]

[33]

Okano T,Sakai H.A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide)..J Biomed Mater Res1993;27:1243-51

[34]

Mitani G,Lee JIK,Ishihara M.The properties of bioengineered chondrocyte sheets for cartilage regeneration..BMC Biotechnol2009;9:17 PMCID:PMC2662823

[35]

Kaneshiro N,Ishihara M,Sakai H.Bioengineered chondrocyte sheets may be potentially useful for the treatment of partial thickness defects of articular cartilage..Biochem Biophys Res Commun2006;349:723-31

[36]

Sato M,Hamahashi K,Mochida J.Articular cartilage regeneration using cell sheet technology..Anat Rec (Hoboken)2014;297:36-43

[37]

Demoor M,Gomez-Leduc T,Hervieu M.Cartilage tissue engineering: Molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction..Biochim Biophys Acta2014;1840:2414-40

[38]

Barron V,Shaw G,Hayes JS.Evaluation of cartilage repair by mesenchymal stem cells seeded on a PEOT/PBT scaffold in an osteochondral defect..Ann Biomed Eng2015;43:2069-82

[39]

Qi BW,Zhu SB,Wu G.Chitosan/poly(vinyl alcohol) hydrogel combined with Ad-hTGF-β1 transfected mesenchymal stem cells to repair rabbit articular cartilage defects..Exp Biol Med2013;238:23-30

[40]

Kim YS,Choi YJ,Heo DB.Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis..Am J Sports Med2015;43:2738-46

[41]

Majewski M,Klaus S.Epidemiology of athletic knee injuries: a 10-year study..The Knee2006;13:184-8

[42]

Dhollander A,Verdonk R.Treatment of painful, irreparable partial meniscal defects with a polyurethane scaffold: midterm clinical outcomes and survival analysis..Am J Sports Med2016;44:2615-21

[43]

Ahmed AM.In-vitro measurement of static pressure distribution in synovial joints--Part I: tibial surface of the knee..J Biomech Eng1983;105:216-25

[44]

Baratz ME,Mengato R.Meniscal tears: the effect of meniscectomy and of repair on intraarticular contact areas and stress in the human knee. A preliminary report..Am J Sports Med1986;14:270-5

[45]

Roos H,Adalberth T,Jonsson K.Knee osteoarthritis after meniscectomy: prevalence of radiographic changes after twenty-one years, compared with matched controls..Arthritis Rheum1998;41:687-93

[46]

Leroy A,Faivre B,Boisrenoult P.Actifit® polyurethane meniscal scaffold: MRI and functional outcomes after a minimum follow-up of 5 years..Orthop Traumatol Surg Res OTSR2017;103:609-14

[47]

Schüttler KF,Gesslein M,Figiel J.Midterm follow-up after implantation of a polyurethane meniscal scaffold for segmental medial meniscus loss: maintenance of good clinical and MRI outcome..Knee Surg Sports Traumatol Arthrosc Off J ESSKA2016;24:1478-84

[48]

Angele P,Kujat R,Nerlich M.Stem cell based tissue engineering for meniscus repair..J Biomed Mater Res A2008;85:445-55

[49]

Dutton AQ,Goh JCH,Hui JHP.Enhancement of meniscal repair in the avascular zone using mesenchymal stem cells in a porcine model..J Bone Joint Surg Br2010;92:169-75

[50]

Olivos-Meza A,Granados-Montiel J,Cortés González S.First clinical application of polyurethane meniscal scaffolds with mesenchymal stem cells and assessment of cartilage quality with T2 mapping at 12 months..Cartilage2019;194760351985241:

[51]

Lai RC,Lim SK.Mesenchymal stem cell exosomes..Semin Cell Dev Biol2015;40:82-8

[52]

Chen TS,Lee MM,Lee CN.Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs..Nucleic Acids Res2010;38:215-24 PMCID:PMC2800221

[53]

Karlsen TA,Mikkelsen TS.microRNA-140 targets RALA and regulates chondrogenic differentiation of human mesenchymal stem cells by translational enhancement of SOX9 and ACAN..Stem Cells Dev2014;23:290-304

[54]

Liang Y,Xiong J,Liu Q.E2 regulates MMP-13 via targeting miR-140 in IL-1β-induced extracellular matrix degradation in human chondrocytes..Arthritis Res Ther2016;18:105 PMCID:PMC4863330

[55]

Miyaki S,Inoue A,Ito Y.MicroRNA-140 plays dual roles in both cartilage development and homeostasis..Genes Dev2010;24:1173-85 PMCID:PMC2878654

[56]

Tao SC,Zhang YL,Guo SC.Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model..Theranostics2017;7:180-95 PMCID:PMC5196895

[57]

Yu XM,Yuan XL,Guo QY.MicroRNAs’ involvement in osteoarthritis and the prospects for treatments..Evid Based Complement Alternat Med2015;2015:1-13 PMCID:PMC4637488

[58]

Toh WS.MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment..Dev Biol2017;9:

[59]

Toghraie F,Gholipour MA,Chenari N.Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits..Arch Iran Med2012;15:495-9

[60]

Zhou J,Liu Y,Xu H.Adipose derived mesenchymal stem cells alleviated osteoarthritis and chondrocyte apoptosis through autophagy inducing..J Cell Biochem2019;120:2198-212

[61]

Im GI,Lee KB.Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?.Osteoarthritis Cartilage2005;13:845-53

[62]

Gentile P,Bielli A,Cervelli V.Concise review: the use of adipose-derived stromal vascular fraction cells and platelet rich plasma in regenerative plastic surgery..Stem Cells2017;117-34

[63]

MEDIPOST - The Future of Biotechnology [Internet]. Available from: http://www.medi-post.com/front/eng/stemcell/cartistem.do [Last accessed on 12 Jun 2020]

[64]

Park Y,Lee C,Park Y.Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof-of-concept with 7 years of extended follow-up..Stem Cells Transl Med2017;6:613-21 PMCID:PMC5442809

[65]

Congenital anomalies [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/congenital-anomalies [Last accessed on 12 Jun 2020]

[66]

Holmes LB.Congenital malformations..N Engl J Med1976;295:204-7

[67]

Corsello G.Congenital malformations..J Matern Fetal Neonatal Med2012;25:25-9

[68]

Kumar V,Aster J.Robbins basic pathology.2017;10th EditionElsevier952

[69]

Suutarla S,Ritvanen A,Jero J.Microtia in Finland: comparison of characteristics in different populations..Int J Pediatr Otorhinolaryngol2007;71:1211-7

[70]

Eavey RD.Microtia and significant auricular malformation. Ninety-two pediatric patients..Arch Otolaryngol Head Neck Surg1995;121:57-62

[71]

Kelley PE.Microtia and congenital aural atresia..Otolaryngol Clin North Am2007;40:61-80vi

[72]

Aguinaga-Ríos M,Arenas-Aranda DJ.Microtia-atresia: aspectos clínicos, genéticos y genómicos..Bol Méd Hosp Infant México2014;71:387-95

[73]

Anderka MT,Abuelo DN,Rasmussen SA.Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature..Am J Med Genet A2009;149A:1241-8

[74]

González-Andrade F,Espín VH.High altitude and microtia in Ecuadorian patients..J Neonatal-Perinat Med2010;3:109-16

[75]

Luquetti DV,Mastroiacovo P.Microtia-anotia: a global review of prevalence rates..Birth Defects Res A Clin Mol Teratol2011;91:813-22 PMCID:PMC3405852

[76]

Tanzer RC.Total reconstruction of the external ear..Plast Reconstr Surg Transplant Bull1959;23:1-15

[77]

Brent B.The correction of mi-rotia with autogenous cartilage grafts: I. The classic deformity?.Plast Reconstr Surg1980;66:1-12

[78]

Peer LA.Extended use of diced cartilage grafts..Plast Reconstr Surg1946;1954;14:178-85

[79]

Vacanti CA.Bone and cartilage reconstruction with tissue engineering approaches..Otolaryngol Clin North Am1994;27:263-76

[80]

Rodriguez A,Ibarra C,Vacanti M.Characteristics of cartilage engineered from human pediatric auricular cartilage..Plast Reconstr Surg1999;103:1111-9

[81]

Otto IA,Zhao X,Kon M.Auricular reconstruction using biofabrication-based tissue engineering strategies..Biofabrication2015;7:032001

[82]

Cohen BP,Puetzer JL,Asanbe O.Long-term morphological and microarchitectural stability of tissue-engineered, patient-specific auricles in vivo..Tissue Eng Part A2016;22:461-8 PMCID:PMC4800266

[83]

Liao HT,Liu W,Cao Y.Prefabricated, ear-shaped cartilage tissue engineering by scaffold-free porcine chondrocyte membrane..Plast Reconstr Surg2015;135:313e

[84]

Zhou G,Yin Z,Zhang Q.In vitro regeneration of patient-specific ear-shaped cartilage and its first clinical application for auricular reconstruction..EBioMedicine2018;28:287-302 PMCID:PMC5835555

[85]

Kamil SH,Vacanti CA.Microtia chondrocytes as a donor source for tissue-engineered cartilage..Laryngoscope2004;114:2187-90

[86]

Domm C,Christesen K.Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension..Osteoarthritis Cartilage2002;10:13-22

[87]

Gu Y,Dong P,Wang Q.Chondrocytes from congenital microtia possess an inferior capacity for in vivo cartilage regeneration to healthy ear chondrocytes..J Tissue Eng Regen Med2018;12:e1737-46

[88]

Hendriks J,Ca van B.Co-culture in cartilage tissue engineering..J Tissue Eng Regen Med2007;1:170-8

[89]

Cai Z,Jiang H.Chondrogenesis of human adipose-derived stem cells by in vivo co-graft with auricular chondrocytes from Microtia..Aesthetic Plast Surg2015;39:431-9

[90]

Goh BS,Ubaidah MA,Sulaiman S.Chondrogenesis of human adipose derived stem cells for future microtia repair using co-culture technique..Acta Otolaryngol (Stockh)2017;137:432-41

[91]

Kang N,Guan Y,Gong F.Effects of co-culturing BMSC and auricular chondrocytes on the elastic modulus and hypertrophy of tissue engineered cartilage..Biomaterials2012;33:4535-44

[92]

Morrison KA,Asanbe O,Harper A.Optimizing cell sourcing for clinical translation of tissue engineered ears..Biofabrication2016;9:015004

[93]

Pleumeekers MM,Koevoet WLM,Stok KS.Cartilage regeneration in the head and neck area: combination of ear or nasal chondrocytes and mesenchymal stem cells improves cartilage production..Plast Reconstr Surg2015;136:762e-74

[94]

Zhang X,Zhou J,Huang H.Chondrogenic differentiation of bone marrow-derived stem cells cultured in the supernatant of elastic cartilage cells..Mol Med Rep2015;12:5355-60

[95]

Cohen BP,Morrison KA,Bonassar LJ.Lammi MJ.Tissue engineering the human auricle by auricular chondrocyte-mesenchymal stem cell co-implantation..PLoS One2018;13:e0202356 PMCID:PMC6200177

[96]

Arrendares S.Análisis genético del labio y paladar hendido solo. Estudio en población mexicana..Rev Invest Clin1974;26:

[97]

Trigos-Micoló I.Análisis de la incidencia, prevalencia y atención del labio y paladar hendido en México..Cir Plástica2003;13:35-9

[98]

Taher A.Cleft lip and palate: lesions, pathophysiology, and primary treatment..J Craniofac Surg2001;12:200

[99]

Vig KW.Alveolar bone grafts: the surgical/orthodontic management of the cleft maxilla..Ann Acad Med Singapore1999;28:721-7

[100]

Waite PD.Bone grafting for the alveolar cleft defect..Semin Orthod1996;2:192-6

[101]

Lilja J,Friede H.Combined bone grafting and delayed closure of the hard palate in patients with unilateral cleft lip and palate: facilitation of lateral incisor eruption and evaluation of indicators for timing of the procedure..Cleft Palate Craniofac J2000;37:98-105

[102]

da Silva Filho OG,Ozawa TO.Secondary bone graft and eruption of the permanent canine in patients with alveolar clefts: literature review and case report..Angle Orthod2000;70:174-8

[103]

Eufinger H.Iliac crest donor site morbidity following open and closed methods of bone harvest for alveolar cleft osteoplasty..J Craniomaxillofac Surg2000;28:31-8

[104]

Dawson KH,Myall RW.Pain following iliac crest bone grafting of alveolar clefts..J Craniomaxillofac Sur1996;24:151-4

[105]

Steinberg B,Boyne P.State of the art in oral and maxillofacial surgery: treatment of maxillary hypoplasia and anterior palatal and alveolar clefts..Cleft Palate Craniofac J1999;36:283-91

[106]

Schliephake H,Planck H,Stern U.Alveolar ridge repair using resorbable membranes and autogenous bone particles with simultaneous placement of implants: an experimental pilot study in dogs..Int J Oral Maxillofac Implants2000;15:364-73

[107]

Rüdiger SG,Hommens A,Flemmig TF.Guided tissue regeneration using a polylactic acid barrier. Part I: Environmental effects on bacterial colonization..J Clin Periodontol2003;30:19-25

[108]

Mellonig JT,Sanchez R.Evaluation of a bioabsorbable physical barrier for guided bone regeneration. Part II. Material and a bone replacement graft..Int J Periodontics Restorative Dent1998;18:129-37

[109]

Lekovic V,Weinlaender M,Vasilic N.Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans..J Periodontol2001;72:583-9

[110]

Piette E,Samman N.Experience with e-PTFE membrane application to bone grafting of cleft maxilla..Int J Oral Maxillofac Surg1995;24:327-32

[111]

Puumanen K,Ritsilä V,Törmälä P.A novel bioabsorbable composite membrane of Polyactive 70/30 and bioactive glass number 13--93 in repair of experimental maxillary alveolar cleft defects..J Biomed Mater Res B Appl Biomater2005;75:25-33

[112]

Aichelmann-Reidy ME,Reynolds MA.Clinical evaluation of calcium sulfate in combination with demineralized freeze-dried bone allograft for the treatment of human intraosseous defects..J Periodontol2004;75:340-7

[113]

Yukna RA,Callan DP,Cruz R.Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results..J Periodontol2000;71:1671-9

[114]

Kiliç AR,Yilmaz S.Guided tissue regeneration in conjunction with hydroxyapatite-collagen grafts for intrabony defects. A clinical and radiological evaluation..J Clin Periodontol1997;24:372-83

[115]

Rabie AB.Clinical applications of composite intramembranous bone grafts..Am J Orthod Dentofac Orthop2000;117:375-83

[116]

Méndez R,Patiño B,Martín-Sastre R.Platelet-rich plasma (platelet gel) in secondary alveoloplasty in cleft patients..Cir Pediatr2006;19:23-6

[117]

Segura-Castillo JL,González-Ojeda A.Reduction of bone resorption by the application of fibrin glue in the reconstruction of the alveolar cleft..J Craniofac Surg2005;16:105-12

[118]

Zybutz MD,Rapoport DA.Treatment of intrabony defects with resorbable materials, non-resorbable materials and flap debridement..J Clin Periodontol2000;27:169-78

[119]

Boyne PJ.Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects..J Bone Joint Surg Am2001;83:S146-50

[120]

Peled M,Horwitz J.Treatment of osseous cleft palate defects: a preliminary evaluation of novel treatment modalities..Cleft Palate-Craniofacial J2005;42:344-8

[121]

Trejo PM,Caffesse R.Treatment of intraosseous defects with bioabsorbable barriers alone or in combination with decalcified freeze-dried bone allograft: a randomized clinical trial..J Periodontol2000;71:1852-61

[122]

Murphy KG.Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. A systematic review..Ann Periodontol2003;8:266-302

[123]

Carpio L,Lynch S.Guided bone regeneration around endosseous implants with anorganic bovine bone mineral. A randomized controlled trial comparing bioabsorbable versus non-resorbable barriers..J Periodontol2000;71:1743-9

[124]

Reynolds MA,Branch-Mays GL.The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review..Ann Periodontol2003;8:227-65

[125]

Nyberg EL,Hung BP,Garcia JR.3D-printing technologies for craniofacial rehabilitation, reconstruction, and regeneration..Ann Biomed Eng2017;45:45-57 PMCID:PMC5154778

[126]

Hixon KR,Lin AY,Sell SA.Cryogel scaffolds from patient-specific 3D-printed molds for personalized tissue-engineered bone regeneration in pediatric cleft-craniofacial defects..J Biomater Appl2017;32:598-611

[127]

Martín-Del-Campo M,Rojo L.Biomaterials for Cleft Lip and Palate Regeneration..Int J Mol Sci2019;20: PMCID:PMC6540257

[128]

Gerhardt LC.Bioactive glass and glass-ceramic scaffolds for bone tissue engineering..Mater Basel Switz2010;3:3867-910 PMCID:PMC5445790

[129]

Janssen NG,van Hout WMMT,Gawlitta D.Microstructured β-tricalcium phosphate putty versus autologous bone for repair of alveolar clefts in a goat model..Cleft Palate-Craniofacial J2017;54:699-706

[130]

Al-Ahmady HH,Bellah Ahmed NEM,Elmasry M.Combining autologous bone marrow mononuclear cells seeded on collagen sponge with Nano Hydroxyapatite, and platelet-rich fibrin: reporting a novel strategy for alveolar cleft bone regeneration..J Craniomaxillofac Surg2018;46:1593-600

[131]

Batool F,Petit C,Bornert F.Periodontal tissues, maxillary jaw bone, and tooth regeneration approaches: from animal models analyses to clinical applications..Nanomater Basel Switz2018;8: PMCID:PMC5977351

[132]

Yoshioka M,Tanne Y,Awada T.Bone regeneration in artificial jaw cleft by use of carbonated hydroxyapatite particles and mesenchymal stem cells derived from iliac bone..Int J Dent2012;2012:352510 PMCID:PMC3320030

[133]

Tanimoto K,Yoshioka M,Tanne Y.Experimental tooth movement into new bone area regenerated by use of bone marrow-derived mesenchymal stem cells..Cleft Palate Craniofac J2015;52:386-94

[134]

Sumi K,Kunimatsu R,Tsuka Y.The effect of mesenchymal stem cells on chemotaxis of osteoclast precursor cells..J Oral Sci2018;60:221-5

[135]

Ahn G,Yun WS,Lee UL.Cleft alveolus reconstruction using a three-dimensional printed bioresorbable scaffold with human bone marrow cells..J Craniofac Surg2018;29:1880-3

[136]

Pourebrahim N,Shahnaseri S,Mousavi B.A comparison of tissue-engineered bone from adipose-derived stem cell with autogenous bone repair in maxillary alveolar cleft model in dogs..Int J Oral Maxillofac Surg2013;42:562-8

[137]

Lee JM,Park JS,Zhang S.Developing palatal bone using human mesenchymal stem cell and stem cells from exfoliated deciduous teeth cell sheets..J Tissue Eng Regen Med2019;13:319-27

[138]

Nakajima K,Ando K,Hayashi Y.Comparison of the bone regeneration ability between stem cells from human exfoliated deciduous teeth, human dental pulp stem cells and human bone marrow mesenchymal stem cells..Biochem Biophys Res Commun2018;497:876-82

PDF

310

Accesses

0

Citation

Detail

Sections
Recommended

/